The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells

被引:125
作者
Aseffa, A
Gumy, A
Launois, P
MacDonald, HR
Louis, JA
Tacchini-Cottier, F
机构
[1] Univ Lausanne, Inst Biochem, WHO, Immunol Res & Training Ctr, CH-1066 Epalinges, Switzerland
[2] Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland
关键词
D O I
10.4049/jimmunol.169.6.3232
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility and development of Th2 cells in BALB/c mice infected with Leishmania major result from early IL-4 production by Vbeta4V alpha8 CD4(+) T cells in response to the Leishmania homolog of mammalian RACK1 Ag. A role for CD4(+)CD25(+) regulatory T cells in the control of this early IL-4 production was investigated by depleting in vivo this regulatory T cell population. Depletion induced an increase in the early burst of IL-4 mRNA in the draining lymph nodes of BALB/c mice, and exacerbated the course of disease with higher levels of IL-4 mRNA and protein in their lymph nodes. We further showed that transfer of 107 BALB/c spleen cells that were depleted of CD4(+)CD25(+) regulatory T cells rendered SCID mice susceptible to infection and allowed Th2 differentiation while SCID mice reconstituted with 10(7) control BALB/c spleen cells were resistant to infection with L. major and developed a Th1 response. Treatment with a mAb against IL-4 upon infection with L major in SCID mice reconstituted with CD25-depleted spleen cells prevented the development of Th2 polarization and rendered them resistant to infection. These results demonstrate that CD4(+)CD25(+) regulatory T cells play a role in regulating the early IL-4 mRNA and the subsequent development of a Th2 response in this model of infection.
引用
收藏
页码:3232 / 3241
页数:10
相关论文
共 58 条
[1]   Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment [J].
Annacker, O ;
Burlen-Defranoux, O ;
Pimenta-Araujo, R ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3573-3580
[2]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[3]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[4]  
CHATELAIN R, 1992, J IMMUNOL, V148, P1182
[5]   Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells [J].
Chen, WJ ;
Jin, WW ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1849-1857
[6]   The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery [J].
Ernst, B ;
Lee, DS ;
Chang, JM ;
Sprent, J ;
Surh, CD .
IMMUNITY, 1999, 11 (02) :173-181
[7]   USE OF THE CTL44 CELL-LINE, A DERIVATIVE OF CTL/L CELLS, TO IDENTIFY AND QUANTIFY MOUSE INTERLEUKIN-4 BY BIOASSAY [J].
FAVRE, N ;
ERB, P .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 164 (02) :213-220
[8]   Selecting and maintaining a diverse T-cell repertoire [J].
Goldrath, AW ;
Bevan, MJ .
NATURE, 1999, 402 (6759) :255-262
[9]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[10]  
Heinzel FP, 1999, INFECT IMMUN, V67, P6454